Healthequity (HQY) Depreciation & Amortization (CF) (2013 - 2026)

Healthequity's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $38.2 million for Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 1.36% year-over-year to $38.2 million in Q2 2026; TTM through Apr 2026 was $154.1 million, a 5.01% decrease from a year earlier, with the FY2026 full-year figure at $154.7 million, down 4.8% from the prior year.
• Depreciation & Amortization (CF) fell to $38.2 million in Q2 2026 per HQY's latest filing, from $38.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $43.6 million in Q3 2024 and bottomed at $37.8 million in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $38.9 million (2022), against an average of $39.4 million.
• Across the five-year window, Depreciation & Amortization (CF) increased 27.63% in 2022 and decreased 11.82% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $40.5 million in 2022, then fell by 6.72% to $37.8 million in 2023, then advanced by 7.78% to $40.7 million in 2024, then declined by 4.77% to $38.8 million in 2025, then retreated by 1.46% to $38.2 million in 2026.
• Per Business Quant, the three latest HQY Depreciation & Amortization (CF) figures stand at $38.2 million (Q2 2026), $38.7 million (Q1 2026), and $38.8 million (Q4 2025).